The effect of nebulized lidocaine 2% in patients sedation during awake intubation

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180806040724N2

Enrollment

Registered

2019-01-01

Start date

2019-01-08

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhalation sedation. Inhaled anaesthetics

Interventions

Intervention group: Nebulized lidocaine 2% with a dose of 3 mg/kg and 6 Lit/min flow rate for 10 minutes.

Eligibility

Sex/Gender

All

Age

14 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who candidates undergoing awake intubation History of difficult intubations Patients over 14 years and below 70 years

Exclusion criteria

Exclusion criteria: Lack of cooperation (if the awake intubation is not essential) History of liver and kidney disease and coagulation Pathology of the respiratory tract Pregnancy Patients who have long received opioid or sedative medications Aspiration and regurgitation probability

Design outcomes

Primary

Measure	Time frame
Depth of sedation. Timepoint: 3 minutes after sedation with midazolam and 10 minutes after inhalation of lidocaine nebulizer 2%. Method of measurement: Bispecteral (BIS) index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParya Arad

Tabriz University of Medical Sciences

paryaarad92@gmail.com+98 41 3337 6925

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026